John C. Pepia Sells 3,000 Shares of MEDNAX Inc (MD) Stock

MEDNAX Inc (NYSE:MD) insider John C. Pepia sold 3,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 22nd. The shares were sold at an average price of $46.43, for a total transaction of $139,290.00. Following the completion of the sale, the insider now owns 39,716 shares of the company’s stock, valued at $1,844,013.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

NYSE MD opened at $46.79 on Friday. The firm has a market cap of $4.42 billion, a PE ratio of 14.85, a PEG ratio of 1.19 and a beta of 0.26. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.74 and a current ratio of 1.74. MEDNAX Inc has a 52 week low of $40.56 and a 52 week high of $63.04.

MEDNAX (NYSE:MD) last posted its quarterly earnings results on Monday, April 30th. The company reported $0.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.07. The firm had revenue of $901.90 million for the quarter, compared to analysts’ expectations of $903.75 million. MEDNAX had a net margin of 9.34% and a return on equity of 10.13%. The firm’s quarterly revenue was up 7.9% on a year-over-year basis. During the same period in the prior year, the company posted $0.75 earnings per share. equities research analysts anticipate that MEDNAX Inc will post 3.94 earnings per share for the current year.

Several equities research analysts have issued reports on the stock. Zacks Investment Research downgraded shares of MEDNAX from a “hold” rating to a “sell” rating in a research note on Wednesday, April 11th. JPMorgan Chase & Co. boosted their price objective on shares of MEDNAX from $46.00 to $55.00 and gave the stock a “neutral” rating in a research note on Monday, February 12th. BMO Capital Markets boosted their price objective on shares of MEDNAX from $46.00 to $58.00 and gave the stock a “market perform” rating in a research note on Monday, February 12th. Mizuho reiterated a “neutral” rating and set a $53.00 price objective (up from $49.00) on shares of MEDNAX in a research note on Friday, February 9th. Finally, Jefferies Group set a $50.00 price objective on shares of MEDNAX and gave the stock a “hold” rating in a research note on Tuesday, February 6th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $55.92.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. GHP Investment Advisors Inc. raised its holdings in MEDNAX by 13.8% in the fourth quarter. GHP Investment Advisors Inc. now owns 7,735 shares of the company’s stock valued at $413,000 after acquiring an additional 940 shares in the last quarter. Amalgamated Bank raised its holdings in MEDNAX by 5.9% in the fourth quarter. Amalgamated Bank now owns 18,448 shares of the company’s stock valued at $986,000 after acquiring an additional 1,035 shares in the last quarter. LPL Financial LLC raised its holdings in MEDNAX by 8.9% in the first quarter. LPL Financial LLC now owns 15,153 shares of the company’s stock valued at $843,000 after acquiring an additional 1,233 shares in the last quarter. Macquarie Group Ltd. raised its holdings in MEDNAX by 36.1% in the fourth quarter. Macquarie Group Ltd. now owns 4,900 shares of the company’s stock valued at $262,000 after acquiring an additional 1,300 shares in the last quarter. Finally, Commerce Bank raised its holdings in MEDNAX by 9.6% in the fourth quarter. Commerce Bank now owns 15,868 shares of the company’s stock valued at $848,000 after acquiring an additional 1,393 shares in the last quarter. 97.14% of the stock is currently owned by hedge funds and other institutional investors.

MEDNAX Company Profile

MEDNAX, Inc, together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology, pediatric cardiology, and other pediatric subspecialties physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care; and acute and chronic pain management services.

Receive News & Ratings for MEDNAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDNAX and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply